Hung David - Jun 8, 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Director
Signature
By: /s/ Steven Robbins, Attorney in Fact for David T. Hung
Stock symbol
NVCR
Transactions as of
Jun 8, 2022
Transactions value $
$0
Form type
4
Date filed
6/10/2022, 04:11 PM
Previous filing
Mar 2, 2022
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Restricted Stock Units Award $0 +2.43K +36.15% $0.00 9.14K Jun 8, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Award $0 +4.35K $0.00 4.35K Jun 8, 2022 Ordinary Shares 4.35K $77.25 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.
F2 Options to buy 4,350 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2023 annual general meeting of shareholders.